AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06102707 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fluzopril Combined With Apatinib
Description: Fluzopril Capsules 100mg po bid Apatinib Mesylate Tablets 250mg po qd
Study NCT05887973 — intervention group
Intervention type: BEHAVIORAL
Intervention: The T.R.I.G.G.E.R Project
Description: The T.R.I.G.G.E.R Project includes the following core components to address root causes of gun violence:~* Summer Employment~* Social and Emotional Learning~* Future Orientation~* Adult and Peer Support~* Critical Consciousness~* Civic Efficacy and Engagement
Study NCT05089383 — intervention group
Intervention type: DRUG
Intervention: Utrogestan
Description: PROSPECTIVE STUDY
Study NCT04997330 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Active rTMS
Description: Bilateral high frequency (20Hz) rTMS will be delivered (over dorsolateral prefrontal cortex), at two daily sessions (left side on the morning and right side on the afternoon), 10 consecutive days on working day, 1500 pulses/session, 110% of motor threshold determined, 30 trains, 50 pulses per train and 15s inter train. A session will typically last around 10 minutes. Alcohol cues consisted of a selection of 60 alcohol-related pictures (beverage, drinking-related behaviors, alcohol-related cues) from the Geneva Appetitive alcohol Pictures will be presented during each rTMS session.
Study NCT04997330 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Sham rTMS
Description: Sham rTMS will be delivered (over dorsolateral prefrontal cortex) , at two daily sessions (left side on the morning and right side on the afternoon), 10 consecutive working days. A session will typically last around 10 minutes. Alcohol cues consisted of a selection of 60 alcohol-related pictures (beverage, drinking-related behaviors, alcohol-related cues) from the Geneva Appetitive alcohol Pictures will be presented during each rTMS session.
Study NCT05221541 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: vibration
Description: whole-body vibration and soleus tendon vibration will be applied to participants
Study NCT04671511 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Targeted Axillary Dissection
Description: Sentinel Node Biopsy (SNB; using Tc99 +/- Blue dye) + Radioactive Seed Localisation (RSL) of clipped node using I125 seed = Targeted Axillary Dissection (TAD)
Study NCT04671511 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Ultrasound of the axilla
Description: Prospectively recorded preoperative ultrasound of the axilla. Number of suspicious nodes recorded. Biopsy and clipping of the positive node.
Study NCT05117606 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: LYNG by Ably Medical
Description: Comparing LYNG to traditional, standard equipment for heart rate, respiration, movement, and blood pressure.
Study NCT04910100 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nebivolol Ophthalmic Suspension 1 Percent
Description: 1 drop instilled into each eye twice daily
Study NCT04910100 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nebivolol Ophthalmic Suspension 0.5 Percent
Description: 1 drop instilled into each eye twice daily
Study NCT04910100 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Timolol Ophthalmic Suspension 0.5 Percent
Description: 1 drop instilled into each eye twice daily
Study NCT04910100 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Timolol Ophthalmic Solution 0.5 Percent
Description: 1 drop instilled into each eye twice daily
Study NCT04924387 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Exercise
Description: All patients will start learning how to activate the abdominal muscles in the first training session. The exercise progression will be adapted according to the capacity of each patient, considering their pain levels. The exercises will be made in 1 to 3 series of among 8 and 15 repetitions and the isometric contractions for 5 to 10 seconds. The rests between series will be of 30 seconds, and between exercises of 2-3 minutes.
Study NCT04924387 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Exercise
Description: All patients will start learning how to activate the abdominal muscles in the first training session. The exercise progression will be adapted according to the capacity of each patient, considering their pain levels. The exercises will be made in 1 to 3 series of among 8 and 15 repetitions and the isometric contractions for 5 to 10 seconds. The rests between series will be of 30 seconds, and between exercises of 2-3 minutes.
Study NCT04871776 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Messaging informed by construal level theory
Description: Messages are informed by construal level theory, which suggests that emphasizing why elicits more abstract thinking, or high-level construals, and can induce an emotional mindset, which could challenge an individual's sense of identity, autonomy, or political preferences. Conversely, emphasizing how is more cognitive and evokes concrete thinking, or low-level construals, and encourages a planning or implementation mindset, which may be better for encouraging vaccine uptake.
Study NCT04871776 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Usual Care
Description: Usual messaging sent by Mass General Brigham
Study NCT06247176 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Sensory Habituation Protocol
Description: The first session continues with the Mock MRI, which lasts 10 minutes. Participant's comfort level in VR will be evaluated.~At the pre-exposure visit, participants complete an MRI scan on a 3 Tesla MRI, which takes approximately 1 hour \& 15 minutes. It consists of structural \& functional MRI scans. Structural scans require the participant to stay still with eyes closed. Functional scans will require the participant to lie with eyes closed or watch and listen to sensory stimulation.~VR exposure will occur across 3 1-hour sessions at most. Participants will be asked to complete a sensory habituation protocol, in which they will watch and listen to sensory stimuli in VR for an increasing amount of time. Between the sensory stimuli, the participant will watch a self-selected video.~Finally, the subject will be asked to do a post-exposure MRI visit, which is the same as the pre-exposure visit.
Study NCT06247176 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Sensory Habituation Protocol
Description: The first session continues with the Mock MRI, which lasts 10 minutes. Participant's comfort level in VR will be evaluated.~At the pre-exposure visit, participants complete an MRI scan on a 3 Tesla MRI, which takes approximately 1 hour \& 15 minutes. It consists of structural \& functional MRI scans. Structural scans require the participant to stay still with eyes closed. Functional scans will require the participant to lie with eyes closed or watch and listen to sensory stimulation.~VR exposure will occur across 3 1-hour sessions at most. Participants will be asked to complete a sensory habituation protocol, in which they will watch and listen to sensory stimuli in VR for an increasing amount of time. Between the sensory stimuli, the participant will watch a self-selected video.~Finally, the subject will be asked to do a post-exposure MRI visit, which is the same as the pre-exposure visit.
Study NCT06494735 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: MyMCT
Description: Using the french version of the metagognitive bibliotherapy MyMCT
Study NCT05875584 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: rbcDNA test
Description: fecal immunochemical test
Study NCT05101252 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: senofilcon A C3
Description: TEST Lens
Study NCT05101252 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Dailies Total 1 Multifocal Contact Lenses
Description: CONTROL Lens
Study NCT06141642 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Self-adaptive serious game
Description: A self-adaptive serious game in immersive virtual reality using the device MetaQuest 1 or 2
Study NCT06141642 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Non-adaptive serious game
Description: A non-adaptive serious game in immersive virtual reality using the device MetaQuest 1 or 2
Study NCT04534829 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Fluoroscopic-guided Radiofrequency Ablation
Description: Radiofrequency ablation of the posterior SIJ complex under fluoroscopic-guidance
Study NCT04534829 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided Radiofrequency Ablation
Description: Radiofrequency ablation of the posterior SIJ complex under ultrasound-guidance
Study NCT06119373 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Single daily icodextrin exchange
Description: PD initiation with single daily exchange of 2-liter icodextrin-based dialysis solution.
Study NCT06119373 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional PD group
Description: PD is initiated with 2 to 3 exchanges of 2-liter glucose-based dialysis solution.
Study NCT04745533 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Antigen detection test
Description: To compare the results of the antigen detection test against the polymerase chain reaction in the study of contacts of COVID-19 patients during quarantine.
Study NCT04982718 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: OraQuick® HCV Self-Test
Description: Self-testing will be performed using the OraQuick® HCV Self-Test manufactured by OraSure Technologies Inc., USA. Modified IFU developed by the manufacturer will be used to adapt the below professional use kits to a self-test: the OraQuick® HCV Rapid Antibody Test is prequalified by WHO and CE marked for professional use (sensitivity 98.1%, specificity 99.6%).~As it is not approved for self-test use in Malaysia, the OraQuick® HCV Self-Test kits provided to participants in the intervention group will be labelled for Research Use Only (RUO) and test results will not be used for patient management.
Study NCT04982718 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: First Response® HCV Self-Test
Description: Self-testing will be performed using the First Response® HCV Card Test (Self Test) manufactured by Premier Medical Corporation, India. Modified IFU developed by the manufacturer will be used to adapt the below professional use kits to a self-test: the First Response® HCV Card Test is CE-marked and currently under WHO review for professional use (sensitivity 100%, specificity 100%).~As it is not approved for self-test use in Malaysia, the First Response® HCV Self-Test kits provided to participants in the intervention group will be labelled for Research Use Only (RUO) and test results will not be used for patient management.
Study NCT06542471 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Dual intramedullary nailing
Description: - Elastic nailing for radius under image guidance through distal entry point and physeal sparing technique.
Study NCT06542471 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Dual plating
Description: - ORIF for radius done first through volar approach.
Study NCT06541821 — intervention group
Intervention type: OTHER
Intervention: survey evaluation
Description: assessment of physical activity, fear of movement, and ostomy compliance
Study NCT06672458 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: MyndMove Short Term Therapy
Description: FES therapy will be provided in one visit (one hour duration) delivered within a 2 week period, in person. FES therapy uses surface electrical stimulation to produce muscle contractions in different combinations to achieve a wide range of reaching and grasping functions. To achieve these movements the single use electrodes will be placed in various combinations on the surface of the different upper arm muscles. Participants will perform hand and finger dexterity tests as well as arm functional mobility tasks while receiving FES.
Study NCT06672458 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventional Short Term Therapy
Description: Therapy will be provided in one visit (one hour duration) delivered within a 2 week period, in person. Conventional therapy will consist of performance hand and finger dexterity tests as well as arm functional mobility tasks
Study NCT04996784 — intervention group
Intervention type: OTHER
Intervention: Capillary blood sampling
Description: The capillary blood sample will be obtained by pricking the fingertip using contact-activated lancet (BD Microtainer). A total of five blood drops (10 μL each) will be collected by a micropipette and will be dropped off on the blotting paper 903 S\&S (Whatman).
Study NCT06672458 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: MyndMove Long Term Therapy
Description: FES upper arm therapy will be provided in one-hour in-person sessions for a maximum of 40 sessions delivered no less than 3 times per week and up to 5 times per week during a period of up to 12 weeks. Over the course of 40 sessions, participants will progress through various movement sequences aimed at regaining natural, unassisted voluntary movements in the affected arms while receiving FES.
Study NCT05652101 — intervention group
Intervention type: OTHER
Intervention: collection of medical data
Description: The data collected concerns:~* Sex~* Age~* Socio-professional category of patients or parents / level of education of the parents~* Family history~* Neonatal patient data (pregnancy, childbirth)~* Clinical data (age of onset of symptoms, evolution of these symptoms over the years, psychomotor development, schooling, learning difficulties, rehabilitation)~* Therapeutic data (treatments tried, their dosage and effectiveness, changes in dosage over the years)~* Paraclinical examinations (Magnetic Resonance Imaging (MRI), scanner, Electroencephalography (EEG))~* Genetic data if available
Study NCT05652101 — intervention group
Intervention type: OTHER
Intervention: Vineland Adaptive Behaviour Scales (VABS2) questionnaire
Description: This is a standardized semi structured interview that measures adaptative skills in 4 areas, in the fields of communication, socialization, daily living, and motricity (for children under 7 years). It can be used for children and adults.~Rating: 2 = yes, usually, 1 = sometimes or partly, 0 = no, never, N = not applicable (when a child is not yet of sufficient age, for example), NS = don't know. The results by domain and by sub-domain are given in raw scores which are then transformed into equivalent ages using a grid provided for this purpose.
Study NCT05796531 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Therapeutic Evaluative Conditioning
Description: Participants are told which pictures are matched pairs. They find the matched pairs among 4 or 8 pictures. By associating pictures and words associated with SITB (e.g., pictures of cut skin, pictures of people engaging in potentially suicidal behaviors, and the word death) with naturally aversive images (e.g., snakes and spiders), it increases the aversion to SITB. The second goal is to increase liking toward the self by pairing self-relevant stimuli (e.g., the participant's name or other self-relevant details, as well as words like I and me).
Study NCT05796531 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Neutral comparison condition
Description: Match neutral pictures to account for doing an intervention.
Study NCT06365931 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Percutaneous neuromodulation
Description: Patients will receive a needle circuit approaching the deep peroneal nerve in an echoguided manner. They will receive a symmetrical biphasic current of 20-30Hz and 250 μs at tolerable intensity.
Study NCT06347419 — intervention group
Intervention type: OTHER
Intervention: Physiotherapy evaluation
Description: In the physiotherapy evaluation, patients' spinal stability, rotary stability, and body awareness will be assessed.
Study NCT06365931 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcutaneous neuromodulation
Description: Patients will have a superficial electrode circuit placed over the belly of the tibialis anterior muscle. They will receive a symmetrical biphasic current of 20-30Hz and 250 μs at tolerable intensity.
Study NCT06365931 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Placebo-percutaneous
Description: Patients will have the neuromodulation circuit placed with needles at 0 intensity, approaching the deep peroneal nerve in an ultrasound-guided manner.
Study NCT06365931 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Placebo-transcutaneous
Description: patients will have the electrodes placed over the tibialis anterior muscle at intensity 0.
Study NCT06365931 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Percutaneous neuromodulation or Transcutaneous neuromodulation (optional)
Description: Study participants who wish to continue may be randomized to receive a 10-session intervention program. The intervention to be received will consist of 10 sessions of percutaneous neuromodulation or 10 sessions of transcutaneous neuromodulation, two sessions per week.
Study NCT06365931 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Percutaneous neuromodulation or Transcutaneous neuromodulation (optional)
Description: Study participants who wish to continue may be randomized to receive a 10-session intervention program. The intervention to be received will consist of 10 sessions of percutaneous neuromodulation or 10 sessions of transcutaneous neuromodulation, two sessions per week.
Study NCT06673550 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Intragastric balloon
Description: Randomized trial comparing fluide-filled intragastric balloon at different filling volumes.
Study NCT04656171 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: MRI of the hand and forearm,
Description: MRI of the hand and forearm,
Study NCT04656171 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: MRI of the hand and forearm,
Description: MRI of the hand and forearm,
Study NCT04127682 — intervention group
Intervention type: OTHER
Intervention: Antibiotic KAP questionnaire
Description: • Self-administered questionnaire will be used and containing following Physician information (age, sex, place of work, specialty, years of experience, place of work, and post graduate studies and trainings), Practice information (number of days for outpatient's practice/week, average number of patients /day and average percentage of children with ARIs/day), Antibiotic prescription practice (using of guidelines and causes of prescribing antibiotics in acute URIs), Knowledge about antibiotic resistance and attendance of any conference or educational activities concerned with antibiotic use during the last year, Attitude as regard antibiotic prescription.
Study NCT05481554 — intervention group
Intervention type: BIOLOGICAL
Intervention: Stool sample
Description: Only 1 stool sample will be collected during the patient hospitalisation scheduled within standard care.
Study NCT05044637 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Primaquine
Description: 7 days of unsupervised primaquine (3.5 mg/kg total dose) administered once per day (0.5 mg/kg OD).
Study NCT05044637 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Primaquine
Description: 7 days of unsupervised primaquine (7.0 mg/kg total dose) administered once per day (1.0 mg/kg OD).
Study NCT05044637 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Primaquine
Description: 14 days of unsupervised primaquine (7mg/kg total dose) administered once per day (0.5 mg/kg).
Study NCT04713228 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ARTSENS Pen
Description: ARTerial Stiffness Evaluation for Noninvasive Screening
Study NCT06158633 — intervention group
Intervention type: DRUG
Intervention: Prevora
Description: Prevora Stage 1, a topical, intra-oral solution of chlorhexidine acetate 100mg/ml followed immediately by Prevora Stage 2 which is a topical solution of polymethylmethacrylate. Prevora Stage 1 and Prevora Stage 2 are applied topically using a small brush and sequentially to the teeth and gum line of the patient/participant.~All subjects will receive at total 4 applications of Prevora 1 and 2. One on Day 1, 14 days, 3 months and 4 months.
Study NCT04713228 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: ARTSENS Pen
Description: ARTerial Stiffness Evaluation for Noninvasive Screening
Study NCT06529276 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Augmented reality clinical learning
Description: Clinical learning of emergency airway management including endotracheal intubation using video laryngoscope and other AGPs, such as bag-valve-mask ventilation, using augmented reality immersive learning technology.
Study NCT05153837 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: saline intravenous administration
Description: Administration of 500 mL of saline (NaCl 0.9%) administered by the venous route
Study NCT05153837 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: oral water
Description: 500 ml oral water
Study NCT05077267 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: ABNCoV2 100ug
Description: IM injection 100ug dose
Study NCT05077267 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: ABNCoV2 50ug
Description: IM injection 50ug dose
Study NCT06529276 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control arm regular clinical learning
Description: Regular bedside learning of emergency airway management including endotracheal intubation using video laryngoscope and other AGPs, such as bag-valve-mask ventilation,
Study NCT05734859 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Electrolyzed Alkaline Ionizer
Description: Patients will drink EHARW calculated by 20 mL/kg body weight/day which can be divided into several times a day for drinking. The patient is recommended to drink water in an empty stomach and to drink water generated from the device as soon as possible.
Study NCT06701396 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tasimelteon
Description: Oral capsule
Study NCT06701396 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Oral capsule